Nasal spray of party drug shows promise as fast-acting antidepressant, researchers say
The latest clinical trial of esketamine, the nasal-spray form of the club drug ketamine, is boosting confidence among some psychiatrists that it could be a major advance in the treatment of suicidal depression. In a study published this week in the American Journal of Psychiatry, researchers report that an esketamine trial resulted in a “rapid improvement in depressive symptoms” […]
Related:
Federal substance abuse chief cancels contracts — and roils longtime agency partners
E. coli outbreak spreads as source of tainted lettuce remains a mystery
First marijuana-derived drug poised for FDA approval after winning support from advisers
Thanks For You Reading The Post
We are very happy for you to come to our site. Our Website Domain name
https://leomedtrends.blogspot.com/.
Newer Posts
Newer Posts
Older Posts
Older Posts
Main Page
Comments